Market revenue in 2024 | USD 1,144.8 million |
Market revenue in 2030 | USD 2,284.6 million |
Growth rate | 12.2% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.39% in 2024. Horizon Databook has segmented the North America pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The North American pancreatic cancer treatment market holds a substantial share of the global market due to advanced healthcare infrastructure, high awareness levels, and significant investment in research and development.
The region accounted for the majority of the global pancreatic cancer market, with the United States being the largest contributor.
The prevalence of pancreatic cancer in North America is notable. The five-year survival rate for pancreatic cancer in the region remains low at around 12%, reflecting the critical need for innovative treatments.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pancreatic cancer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account